| Regeneron Pharmaceuticals | 586.4100 / +0.93% |
| Date/Time | 07/28 / 22:00 |
| Chg. / Chg.(%) | 5.4000 / +0.93% |
| Bid | 562.0000 / 100 |
| Ask | 595.4400 / 100 |
| Open | 582.0400 |
| Previous Close | 581.0100 |
| High | 587.9200 |
| Low | 579.0000 |
| Volume [USD] | 125,313,474.3192 |
| Volume [Units] | 404,036 |
| Price fixings | 1197 |
| ISIN | US75886F1075 |
| Security | REGN |
| Exchange | NASDAQ |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| TradeGate | 488.500 |  |
132 |
| Moscow | 42,746.00 |  |
44 |
| Xetra | 488.45 | |
2 |
| Hamburg | 491.75 | |
0 |
| Hannover | 491.75 | |
0 |
| Frankfurt | 492.6500 | |
0 |
| Düsseldorf | 488.50 | |
0 |
| Berlin | 492.80 | |
0 |
| München | 492.10 | |
0 |
| Vienna Globa.. | 495.95 | |
0 |
| gettex | 493.200 | |
|
| Lang & Schwa.. | 488.65 | |
|
| Stuttgart | 493.500 | |
|
| Quotrix | 495.1000 | |
|
| NASDAQ | 586.4100 | |
404,036 |
| IEX | 586.82 |  |
31,275 |
| Cboe US | 586.32 | 12,838 | |
| London Inter.. | 582.33 | 1,149 | |
| Mexico | 11,424.86 | |
1,681 |
News
- Dupixent® (dupilumab) significantly improved itch and hives in patients with chronic spontaneous urticaria, a step forward in demonstrating the role of type 2 inflammation in these patients
07:00 - GlobeNewswire - SpringWorks Therapeutics Appoints Dr. James Cassidy as Chief Medical Officer
07/27/2021 / 14:00 - GlobeNewswire - Ziopharm Oncology to Report Second Quarter Financial Results on August 9, 2021
07/26/2021 / 22:30 - GlobeNewswire - Kiniksa Pharmaceuticals to Report Second Quarter 2021 Financial Results on August 3, 2021
07/20/2021 / 22:01 - GlobeNewswire - US closes higher, S&P hits sixth consecutive record high
07/01/2021 / 22:01 - TeleTrader
Real-time